Rather recently, Wolk and colleagues have found that lipocalin-2 (LCN2) was significantly upregulated in the serum (and highly expressed in lesional skin) of HS patients compared to healthy participants, demonstrating a positive correlation between LCN2 blood levels and disease activity (Sartorius score). Here, LCN2 is linked to histiocytic sarcoma.